• COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blog
  • Contact Us
Menu
  • COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blog
  • Contact Us
  • About Us
    • Executive Leadership
    • Awards And Recognitions​
    • Certifications
    • Quality Management
    • Environment, Health,
      Safety & Sustainability
    • Corporate Social Responsibility
  • Solutions
    Small Molecules
    Large Molecules
    Other Drug Modalities
    SynVent Integrated Drug Discovery
    Industries
    Dedicated Centers
    Center for Advanced Protein Studies (CAPS)
    Discovery
    • Chemistry
    • Biology
    • Safety Assessment
    • Research Informatics
    Development
    • Chemical Development
    • Formulation Development
    • Analytical Development
    • Clinical Development
    Manufacturing
    • Commercial Manufacturing
    Discovery
    • molecular biology
    • protein sciences
    • Cell line development & analysis
    • antibody generation
    Development & Manufacturing
    • Development and Manufacturing Services
    • Analytical Characterization & Quality Control
    • Viral Testing & Clearance
    • Bioanalytical Laboratory Services
    • Peptides
    • Oligonucleotides
    • Antibody Drug Conjugates
    • PROTACs
    • CAR-T

    SynVent Integrated Drug Discovery

    SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    Know More
    Know More
    • Pharmaceutical & Biotech
    • Animal Health
    • Agrochemical
    • Nutrition
    • Specialty & Performance Chemicals/Others

    Dedicated Centers

    Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    Know More
    Know More

    Center for Advanced Protein Studies (CAPS)

    Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

    Know More
    Know More
    • Small Molecule
      • List Item #1
      • List Item #2
      • List Item #3
      • List Item #1
      • List Item #2
      • List Item #3
      • List Item #1
      • List Item #2
      • List Item #3
    • Industries
    • Dedicated Centres
    • Center for Advanced Protein Studies (CAPS)
    Menu
    • Small Molecule
      • Chemistry
      • Other Drug Modalities
      • Large Molecule
    • Industries
    • Dedicated Centres
    • Center for Advanced Protein Studies (CAPS)
  • Investors
    • Overview
    • Investor Fact Sheet
    • Financial Information
    Corporate Governance
    • Governance Structure
    • Board Of Directors
    • Committees To The Board
    • Our Leadership
    • Corporate Structure
    • Governance Reports & Policies
    • Share Holder Services
    • Stock Exchange Disclosures
    • Analyst Coverage
    • Investor Calendar
    • Investor Contact
  • Careers
  • News & Events
    • Press Release
    • In the Media
    • Events
  • Insights & Resources
  • Group Companies
    • Biocon
    • Biocon Biologics
    • BICARA
    • Biocon Academy
Menu
  • About Us
    • Executive Leadership
    • Awards And Recognitions​
    • Certifications
    • Quality Management
    • Environment, Health, Safety & Sustainability
    • Corporate Social Responsibility
  • Solutions
    • Small Molecules
    • Discovery
    • Chemistry
    • Biology
    • Safety Assessment
    • Research Informatics
    • Development
    • Chemical development
    • Formulation development
    • Clinical Development
    • Analytical Development
    • Manufacturing
    • Commercial Manufacturing
    • Large Molecules
    • Discovery
    • Molecular Biology
    • Protein Sciences
    • Cell Line Development & Analysis
    • Antibody Generation
    • Development & Manufacturing
    • Development and Manufacturing Services
    • Analytical Characterization & Quality Control
    • Viral Testing & Clearance
    • Bioanalytical Laboratory Services
    • Synvent Integrated Drug Discovery
    • Other Drug Modalities
    • Peptides
    • Oligonucleotides
    • Antibody Drug Conjugates
    • PROTACs
    • CAR-T
    • Industries
    • Dedicated Centers
    • Center For Advanced Protein Studies (CAPS)
  • Investors
    • Overview
    • Corporate Governance
    • Financial Information
    • Share holder services
    • Investor Calendar
    • Investor Contact
  • Careers
  • News & Events
    • Press Release
    • In the Media
    • Events
  • Insights & Resources
  • Group Companies
    • Biocon
    • Biocon Biologics
    • BICARA
    • Biocon Academy
  • COVID-19 Updates
  • InstaVisit
  • Blog
  • Contact Us
Search
Close
  • COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blog
  • Contact Us
Menu
  • COVID-19 Updates
  • InstaVisit 360° Virtual Tour
  • Blog
  • Contact Us
  • About Us
    • Executive Leadership
    • Awards And Recognitions​
    • Certifications
    • Quality Management
    • Environment, Health,
      Safety & Sustainability
    • Corporate Social Responsibility
  • Solutions
    • Small Molecules
      • Discovery
        • Chemistry
        • Biology
        • Safety Assessment
        • Research Informatics
        Development
        • Chemical Development
        • Formulation Development
        • Analytical Development
        • Clinical Development
        Manufacturing
        • Commercial Manufacturing
    • Large Molecules
      • Discovery
        • molecular biology
        • protein sciences
        • Cell line development & analysis
        • antibody generation
        Development & Manufacturing
        • Development and Manufacturing Services
        • Analytical Characterization & Quality Control
        • Viral Testing & Clearance
        • Bioanalytical Laboratory Services
    • Other Drug Modalities
        • Peptides
        • Oligonucleotides
        • Antibody Drug Conjugates
        • PROTACs
        • CAR-T
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
        • Pharmaceutical & Biotech
        • Animal Health
        • Agrochemical
        • Nutrition
        • Specialty & Performance Chemicals/Others
    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
  • Investors
    • Investor
      • Overview
      • Investor Fact Sheet
      • Financial Information
      Corporate Governance
      • Governance Structure
      • Board Of Directors
      • Committees To The Board
      • Our Leadership
      • Corporate Structure
      • Governance Reports & Policies
      • Share Holder Services
      • Stock Exchange Disclosures
      • Analyst Coverage
      • Investor Calendar
      • Investor Contact
  • Careers
  • News & Events
    • Press Release
    • In the Media
    • Events
  • Insights & Resources
    • Blogs
    • Brochures
    • Points Of View
    • Webinars
    • Case Studies
    • Videos
  • Group Companies
    • Biocon
    • Biocon Biologics
    • BICARA
    • Biocon Academy
Search
Close

AACR Annual Meeting 2021

© 2021. Syngene International Limited

Twitter
Linkedin-in
Youtube
Facebook-f

Quick Links

  • About Us
  • Investors
  • Careers
  • News & Events
  • Insights & Resources
  • COVID-19 Updates
  • InstaVisit

Business

  • Discovery
  • Development
  • Manufacturing
  • SynVent Integrated Drug Discovery
  • Industries
  • Dedicated Centers
  • Center For Advanced Protein Studies (CAPS)

Get In Touch

  • Contact Us
  • Investor Contact

Other Links

  • Anti-Bribery Anti-Corruption Statement
  • Disclaimer
  • Privacy Policy
  • Cookie Policy
Twitter
Linkedin-in
Youtube
Facebook-f

© 2021. Syngene International Limited